ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 229 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2019. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,539,955 | -17.5% | 269,403 | -4.8% | 0.01% | 0.0% |
| Q2 2023 | $4,291,083 | +49.9% | 283,053 | +29.0% | 0.01% | +50.0% |
| Q1 2023 | $2,863,392 | +11.8% | 219,417 | +51.1% | 0.00% | 0.0% |
| Q4 2022 | $2,561,540 | -31.9% | 145,212 | -41.0% | 0.00% | -33.3% |
| Q3 2022 | $3,764,000 | +18.6% | 246,031 | +18.3% | 0.01% | +20.0% |
| Q2 2022 | $3,173,000 | +9.8% | 207,986 | +62.0% | 0.01% | +25.0% |
| Q1 2022 | $2,891,000 | +20.5% | 128,401 | -1.3% | 0.00% | +33.3% |
| Q4 2021 | $2,400,000 | +34.2% | 130,064 | -2.8% | 0.00% | +50.0% |
| Q3 2021 | $1,788,000 | -38.0% | 133,763 | -14.1% | 0.00% | -50.0% |
| Q2 2021 | $2,883,000 | +17.6% | 155,761 | -4.6% | 0.00% | 0.0% |
| Q1 2021 | $2,451,000 | -7.7% | 163,282 | -11.3% | 0.00% | 0.0% |
| Q4 2020 | $2,656,000 | -48.2% | 183,992 | -70.8% | 0.00% | -60.0% |
| Q3 2020 | $5,130,000 | -33.8% | 630,321 | -44.9% | 0.01% | -33.3% |
| Q2 2020 | $7,749,000 | -30.5% | 1,144,480 | -27.7% | 0.02% | -37.5% |
| Q1 2020 | $11,146,000 | -53.9% | 1,583,201 | -35.8% | 0.02% | -33.3% |
| Q4 2019 | $24,187,000 | -5.1% | 2,464,355 | +6.2% | 0.04% | -10.0% |
| Q3 2019 | $25,488,000 | +51.0% | 2,321,307 | +59.9% | 0.04% | +53.8% |
| Q2 2019 | $16,879,000 | +1496.9% | 1,451,308 | +1209.5% | 0.03% | +1200.0% |
| Q1 2019 | $1,057,000 | -6.0% | 110,826 | -5.0% | 0.00% | 0.0% |
| Q4 2018 | $1,124,000 | -34.7% | 116,625 | -3.5% | 0.00% | -33.3% |
| Q3 2018 | $1,722,000 | +17.1% | 120,835 | -1.3% | 0.00% | +50.0% |
| Q2 2018 | $1,470,000 | -3.9% | 122,465 | -1.1% | 0.00% | 0.0% |
| Q1 2018 | $1,529,000 | -17.2% | 123,815 | -2.4% | 0.00% | -33.3% |
| Q4 2017 | $1,846,000 | +4.8% | 126,895 | +2.6% | 0.00% | 0.0% |
| Q3 2017 | $1,761,000 | +12.8% | 123,735 | +1.1% | 0.00% | +50.0% |
| Q2 2017 | $1,561,000 | +10.0% | 122,355 | +9.3% | 0.00% | 0.0% |
| Q1 2017 | $1,419,000 | +31.1% | 111,917 | +5.6% | 0.00% | 0.0% |
| Q4 2016 | $1,082,000 | -25.4% | 105,957 | -3.8% | 0.00% | 0.0% |
| Q3 2016 | $1,451,000 | +1.2% | 110,177 | -2.4% | 0.00% | 0.0% |
| Q2 2016 | $1,434,000 | -4.0% | 112,877 | -0.2% | 0.00% | -33.3% |
| Q1 2016 | $1,494,000 | -15.7% | 113,077 | -1.9% | 0.00% | 0.0% |
| Q4 2015 | $1,773,000 | +26.0% | 115,277 | +1.6% | 0.00% | 0.0% |
| Q3 2015 | $1,407,000 | -6.6% | 113,477 | +3.0% | 0.00% | 0.0% |
| Q2 2015 | $1,507,000 | +5.1% | 110,177 | -8.1% | 0.00% | +50.0% |
| Q1 2015 | $1,434,000 | -7.8% | 119,877 | -1.6% | 0.00% | -33.3% |
| Q4 2014 | $1,556,000 | +5.9% | 121,877 | +11.3% | 0.00% | 0.0% |
| Q3 2014 | $1,469,000 | -20.9% | 109,477 | -5.3% | 0.00% | 0.0% |
| Q2 2014 | $1,856,000 | -0.6% | 115,610 | +11.6% | 0.00% | 0.0% |
| Q1 2014 | $1,867,000 | +19.0% | 103,577 | +2.1% | 0.00% | 0.0% |
| Q4 2013 | $1,569,000 | -1.2% | 101,477 | -5.0% | 0.00% | 0.0% |
| Q3 2013 | $1,588,000 | +6.9% | 106,777 | -7.0% | 0.00% | 0.0% |
| Q2 2013 | $1,485,000 | – | 114,777 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 1,375,000 | $20,006,000 | 10.92% |
| Adirondack Research & Management Inc. | 574,033 | $8,352,000 | 3.28% |
| GLENHILL ADVISORS LLC | 2,461,034 | $35,808,000 | 2.64% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,949,600 | $28,367,000 | 2.42% |
| DALTON GREINER HARTMAN MAHER & CO | 2,990,902 | $43,518,000 | 2.28% |
| S&T BANK/PA | 703,223 | $10,231,000 | 1.73% |
| Tibra Equities Europe Ltd | 263,344 | $3,832,000 | 1.64% |
| Millrace Asset Group, Inc. | 116,675 | $1,697,000 | 1.63% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 1,271,450 | $18,502,000 | 1.31% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,423,223 | $137,108,000 | 1.15% |